Navigation Links
AAAS decries latest stem cell veto

The President has again vetoed the Stem Cell Research Enhancement Act, which would expand federal support for embryonic stem cell research. AAAS, the world’s largest general scientific society, stands with a broad coalition of Americans spanning all parties and faiths that supports this bill.

The scientific consensus is that embryonic stem cell research is an extremely promising approach to developing more effective treatments for devastating conditions like diabetes, spinal cord injuries, and Parkinson’s disease. The bill would mandate that such research be allowed to compete for federal funding while following strict ethical guidelines.

The Executive Order is not a substitute for the Stem Cell Research Enhancement Act. The new approaches addressed by the order are still in the early stages of development and appear to already be eligible for NIH funding. AAAS strongly believes that it is only through federal support of diverse avenues of stem cell research that we may better understand the potential value and limitations of each approach.

During his tenure the President has acknowledged that it is a critical time for the American scientific enterprise, therefore it is disappointing that he has chosen to maintain restrictions on such a promising area of research. AAAS will continue to support the interests of scientists and patients in fostering medical progress. The American Association for the Advancement of Science (AAAS) on Wednesday expressed disappointment with the decision by President George W. Bush to veto a landmark stem cell research funding bill.

The measure would have lifted restrictions on federal funding of medical research using embryonic stem cells, which proponents say would be derived from microscopic embryos left over and due to be discarded after in vitro fertility treatments. Current U.S. policy limits such funding to fewer than 20 stem cell lines that had been created when the president first announce d U.S. policy in 2001.

"Our concern is that this action has the potential to delay development of important new therapies by cutting off a promising avenue of research," said Alan I. Leshner, the chief executive officer of AAAS and executive publisher of the journal Science.

The president vetoed a similar bill that passed the Senate and House of Representatives last year. This year's measure won strong bi-partisan support in the U.S. House and Senate, but fell just short of the two-thirds supermajority needed to override the veto.

While Bush signed a separate Executive Order to support other stem cell research, AAAS "strongly believes" that all avenues of stem cell research must be explored, the non-partisan association said a statement.

The following is the full text of the AAAS statement:

"The President has again vetoed the Stem Cell Research Enhancement Act, which would expand federal support for embryonic stem cell research. AAAS, the world's largest general scientific society, stands with a broad coalition of Americans spanning all parties and faiths that supports this bill.

"The scientific consensus is that embryonic stem cell research is an extremely promising approach to developing more effective treatments for devastating conditions like diabetes, spinal cord injuries, and Parkinson's disease. The bill would mandate that such research be allowed to compete for federal funding while following strict ethical guidelines.

"The Executive Order is not a substitute for the Stem Cell Research Enhancement Act. The new approaches addressed by the order are still in the early stages of development and appear to already be eligible for NIH funding. AAAS strongly believes that it is only through federal support of diverse avenues of stem cell research, including especially embryonic stem cell research, that we may better understand the potential value and limitations of each approach.

"During his tenure the President has acknowledged that it is a critical time for the American scientific enterprise, therefore it is disappointing that he has chosen to maintain restrictions on such a promising area of research. AAAS will continue to support the interests of scientists and patients in fostering medical progress."


'"/>

Source:American Association for the Advancement of Science


Related biology news :

1. NHGRI announces latest sequencing targets

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):
(Date:6/22/2017)... , ... June 21, 2017 , ... ... office in North Carolina, and engages Timothy Reinhardt to manage the new site. ... leadership at Pfizer Inc, with his most recent role as the Director of ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... designating infertility as a disease, bringing new hope for prospective parents who are ... annual meeting to back the World Health Organization’s designation in hopes of changing ...
(Date:6/22/2017)... ... 2017 , ... The first human cell line HeLa, established in 1951, has ... cross-contamination of human cell lines with HeLa cells were published. Until recently, cross-contamination and ... and is associated with dramatic consequences for research. , In this educational webinar, ...
(Date:6/20/2017)... ... June 20, 2017 , ... CTNext , ... directors has formed a Higher Education Entrepreneurship Advisory Committee to implement the recommendations ... and other high-ranking representatives from 35 higher education institutions across the state over ...
Breaking Biology Technology: